Cargando…
A Case of Myopericarditis After the Second Dose of mRNA COVID-19 Vaccine in a Patient With a History of Myopericarditis
Vaccination is important for the prevention of coronavirus-induced disease 2019 (COVID-19) caused by SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) and to protect persons with a high risk for complications. There have been reports of myopericarditis following COVID-19 vaccination, espe...
Autores principales: | Fujibayashi, Kosuke, Kajinami, Kouji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9684059/ https://www.ncbi.nlm.nih.gov/pubmed/36439701 http://dx.doi.org/10.1177/11795476221138648 |
Ejemplares similares
-
COVID‐19 mRNA vaccines and myopericarditis
por: Gnanenthiran, Sonali R., et al.
Publicado: (2022) -
Acute Myopericarditis after the Second Dose of mRNA COVID-19 Vaccine Mimicking Acute Coronary Syndrome
por: Pantsios, Chris, et al.
Publicado: (2022) -
Myopericarditis After mRNA COVID-19 Vaccine in a Patient With Recent History of COVID-19
por: Elhouderi, Eiman, et al.
Publicado: (2022) -
mRNA-1273: Myopericarditis: case report
Publicado: (2021) -
Myopericarditis Following the Third Dose of COVID-19 mRNA Vaccination: A Case Report
por: Saeed, Aamir, et al.
Publicado: (2023)